Semma steps toward the clinic after demonstrating effect of potential diabetes cure in landmark animal studies

The research team at the well-funded Semma Therapeutics has cleared one of the last remaining hurdles to getting a potential cure for diabetes into human studies. And if they’re right, it marks a major preclinical milestone for a resurgent regenerative medicine field focused on a new generation of stem cell therapies.